Document is current

Article History

Received: 8 June 2024

Accepted: 6 November 2024

First Online: 21 January 2025

Declarations

:

: IRB approval: Ethics approval was obtained from the Human Ethics Research Committee at the University of Melbourne (#1034161), the Medical Research Centre at Hamad Medical Corporation in Qatar (# 10097).Ethical considerations for the study: this study had a low ethical risk level as there was no clinical intervention nor was there sensitive information obtained from participants. Participating in this study was voluntary and no pressure was put on participants to join the study. A plain language statement was distributed along with the consent form describing the study any possible risks and the measures taken to address them.

: Informed and voluntary consent of participants was obtained after information was provided to participants about the purpose, methods, demands, risks, inconveniences, discomforts and possible outcomes of the research. This information was provided in a written Plain Language Statement. We confirm that all methods were performed in accordance with the relevant guidelines and regulations (Declaration of Helsinki).

: Not applicable.

: The authors declare no competing interests.